Science and Law
6th June 2019

E-Cigarette Litigation is Heating Up and The Science is Too

Manufacturers, retailers, and distributors of e-cigarettes are likely to be defending themselves in against a variety of claims involving these products.

E-Cigarette Litigation is Heating Up and The Science is Too

Manufacturers, retailers, and distributors of e-cigarettes are likely to be defending themselves in against a variety of claims involving these products. The e-cigarette litigation landscape is evolving quickly with several high-profile lawsuits or investigations launched over the past several months by Attorneys General of Massachusetts, Connecticut and North Carolina, a State Prosecutor in an Illinois county, and consumers such as the Nessmith Class Action, Swearingen and Peavy Class Action, and a class-actions that were recently permitted to move forward in San Francisco and West Virginia (among others), and other cases in the wings, such as this one by the Public Health Advocacy Institute (PHAI) at Northeastern University. Further, San Francisco recently banned the sales of e-cigarettes and the state of Vermont imposed a 92% tax on e-cigarettes, while a Connecticut man has sued Juul Labs for allegedly “causing him to suffer a massive stroke after he became addicted to the company’s products as a teenager.” The Beasley Allen firm also recently filed three new cases against an e-cigarette manufacturer, while the Moll Law Group of Chicago recently filed a complaint on behalf of a teen alleging JUUL designed and marketed its products to appeal to young people. In August 2019, a 19-year-old sued JUUL using the Racketeer Influenced and Corrupt Organizations Act, claiming that “the defendants prey on youth for financial gain.”

To date, most lawsuits related to e-cigarettes have been product liability claims such as the “battery exploding e-cigarette lawsuits,” and have been filed by some of the most prominent plaintiff’s attorneys including attorneys from the Motley Rice firm.

BY THE WAY: Check out our other post on e-cigarette expert witnesses. E-cigarette experts will key to mounting an effective defense.

But the latest round of lawsuits allege that defendants have designed and marketed their products to attract young people and have failed to warn consumers about the risks associated with the use of these products, and nicotine specifically. These lawsuits are riding in tandem with the intense scrutiny that e-cigarette companies have come under by regulators and other groups (such as the AAP et al. v. FDA suit) which has generated considerable market uncertainty for e-cigarette manufacturers and retailers, as well as the consumers who have benefit from these products.

In parallel to the shifting litigation and regulatory landscapes is a large volume of scientific information that is being published every week. This emerging body of literature is relevant to both litigation and for regulatory filings such as responses to proposed FDA actions or submissions like the Premarket Tobacco Application (PMTA) (final guidance released by the FDA in June 2019) and Modified Risk Tobacco Product (MRTP) pathways.

The current volume of new science is staggering—an average of ~40 articles relevant to e-cigarettes are being published every week. By using a simple keyword search in the PubMed database, we generated the following graphic which depicts the increase in literature over the past decade.

Keep in mind that this is an underestimate of the actual number of publications since a more sophisticated keyword search strategy and searches of other databases would certainly turn up additional literature. For instance, this search did not comprehensively identify topics related to nicotine, heat-not-burn, and other alternative nicotine delivery systems (ANDS) literature. There are also many source of grey literature that are important to track as well, such as data presented at conference proceedings, including the Global Forum on Nicotine. For interested readers, the proceedings of the 2019 meeting are available online:

As new scientific information continues to emerge and expand, attorneys on both sides will have to adjust their strategies to adapt to new information which will inform about new risks and aid in developing better defenses.

With this level of new publications, it comes as no surprise if you are spending too much time searching for articles and not enough time reading them and understanding their potential impact on litigation or business.

As the e-cigarette litigation and regulatory landscapes shift, don’t get caught off-guard by falling behind on the science. If you are frustrated with your current scientific literature search strategy (on vaping/e-cigarettes or any scientific topic for that matter), get in touch and learn how DataTrove® can save you valuable time and prevent frustration.

 

Science overload? Receive timely science updates related to e-cigarettes.

Sign up for a free 1-month trial. Complete the form and we'll deliver.

  • Hidden
  • This field is for validation purposes and should be left unchanged.

Recent Related Articles

Dr. David Schwartz’s IADC Presentation: The Use of Genetic Testing in the Courtroom [Download Slides]
15 July 2020
Dr. David Schwartz’s IADC Presentation: The Use of Genetic Testing in the Courtroom [Download Slides]

On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more

The Use of Genetic Testing in the Courtroom: Dr. David Schwartz will be Presenting at the IADC 2020 Virtual Annual Meeting
02 July 2020
The Use of Genetic Testing in the Courtroom: Dr. David Schwartz will be Presenting at the IADC 2020 Virtual Annual Meeting

Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more

WEBINAR ANNOUNCEMENT: What’s in Those Genes?
12 June 2020
WEBINAR ANNOUNCEMENT: What’s in Those Genes?

Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Read more

Talc and Asbestos Defendants Should Monitor and Utilize Published Studies Linking Mesothelioma to Genomic Causes
28 April 2020
Talc and Asbestos Defendants Should Monitor and Utilize Published Studies Linking Mesothelioma to Genomic Causes

Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us